Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03889873 · ClinicalTrials.gov registry record · NA
Evaluating Change in Drinking Identity as a Mechanism for Reducing Hazardous Drinking - Study 2
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 329
- Enrollment target
NCT03889873: Completed NA study, sponsored by University of Washington.
NCT03889873 is a NA study that has completed, run by University of Washington. The registered enrollment target is 329 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03889873, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 329 participants
- Enrollment target
Study Summary
The purpose of the proposed research is to evaluate whether changes in drinking identity (DI; how much one associates one's self with drinking) can reduce hazardous drinking (HD; heavy alcohol use and negative alcohol-related consequences) among current college students. The study seeks to explore whether manipulating DI among participants will have changes in self-efficacy, craving, and HD. If such an effect can be found, DI may be a mechanism for HD behavior change and will allow researchers to develop and improve interventions aimed at HD behaviors in high-risk young adults.
Primary Outcome
drinking identity implicit association test (IAT)
Interventions
- BEHAVIORAL Narrative Writing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 329 participants |
| Start Date | 2019-04-18 |
| Est. Completion | 2021-06-07 |
| Phase | NA |
What the finished NCT03889873 record still lists
NCT03889873 is an interventional study that assigns participants to a tested intervention. The registered 329 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 1 intervention - of which Narrative Writing is the first listed.
NCT03889873 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03889873 about?
NCT03889873 is a clinical study titled "Evaluating Change in Drinking Identity as a Mechanism for Reducing Hazardous Drinking - Study 2". The purpose of the proposed research is to evaluate whether changes in drinking identity (DI; how much one associates one's self with drinking) can reduce hazardous drinking (HD; heavy alcohol use and negative alcohol-related consequences) among current college students. The study seeks to explore w...
What is the current status of trial NCT03889873?
This trial is currently completed. It is a NA study. The enrollment target is 329 participants. The study started on 2019-04-18. Estimated completion is 2021-06-07.
What interventions are being tested in trial NCT03889873?
The interventions under investigation include: Narrative Writing (BEHAVIORAL).
Who is sponsoring clinical trial NCT03889873?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03889873's enrollment target sits among peer trials
329 308th of 2000 higher than 1,693 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06036446 · 329 participants · NA
LATe Cerclage in High-risk Pregnancies (LATCH)
- NCT00359684 · 330 participants
Use of Cysteamine in the Treatment of Cystinosis
- NCT03817502 · 330 participants · Phase 3
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
- NCT03922724 · 330 participants · Phase 2
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI